Literature DB >> 16564353

PROactive study.

.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16564353     DOI： 10.1016/S0140-6736(06)68416-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  [Endocrine disorders and the heart].

Authors:  Onno E Janssen; K Mann; R Erbel
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

Review 2.  Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?

Authors:  Jean-Luc Faillie; Pierre Petit; Jean-Louis Montastruc; Dominique Hillaire-Buys
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

Review 3.  Pioglitazone for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C Clar; S H Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.